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stabilized, and his WBC count returned to baseline (1,600/mm 3).
One of two blood cultures yielded an anaerobic gram-positive
bacillus with terminal spores that was later identified as C. parapu-
trificum (RapID ANA II System, Innovative Diagnostic Systems,
Norcross, GA). On identification of the organism (its susceptibility
profile was not determined), antibiotic therapy was changed to
intravenous metronidazole. Two subsequent sets of blood cultures
were negative. The patient again received chemotherapy; however,
on 27 August he died of sepsis due to Staphylococcus epidermidis.
C. paraputrificum is a gram-positive bacillus that forms terminal
spores, is not hemolytic when grown on blood agar plates, and does
not produce toxins. C. paraputrificum is found in the soil, animal
and human feces, and clinical specimens-most notably blood,
wounds, peritoneal fluid, and intraabdominal sources [1]. Various
dietary factors have been associated with decreased levels of
C. paraputrificum in fecal microflora (e.g., a high-fiber diet) [2].
Clostridia account for <1%-3% of all blood culture isolates
[3, 4] and 4%-11% of all anaerobic blood culture isolates [4, 5].
C. paraputrificum accounted for of clostridial isolates from
all clinical specimens recovered at Indiana University Medical
Center from 1979 to 1988 [6]. In reports of clostridial bacteremia,
C. paraputrificum was the sole blood isolate in two of 12 adults
[4] and one of 10 children [7] and in no patients from other series
[3, 5]. Fourteen cases of in which C. paraputrificum was isolated in
blood cultures have been described in the literature. The underlying
conditions associated with these cases included gastrointestinal
pathology, alcohol abuse, aspiration pneumonia, diabetes mellitus,
sickle cell anemia, cyclic neutropenia, and poor nutrition [4,
7-9]. The mortality among patients with sepsis due to this organ-
ism is high but may reflect the severity of underlying disease and
loss of host defense mechanisms.
Of 39 strains of C. paraputrificum reported in Bergey's Manual
of Systematic Bacteriology [1], 35 were resistant to clindamycin,
13 to erythromycin, 3 to tetracycline, 3 to penicillin, and 1 to
chloramphenicol. Six strains were tested by Brazier et al. [10],
who found that 4 were resistant to clindamycin and 1 to penicillin,
and all 6 were susceptible to erythromycin, tetracycline, chloram-
phenicol, ampicillin/sulbactam, and metronidazole. No isolates of
C. paraputrificum in any report were tested against vancomycin.
To our knowledge, this is the first case of C. paraputrificum
bacteremia reported in a patient with AIDS. The presence of pre-
disposing factors for C. paraputrificum bacteremia (gastrointestinal
malignancy, neutropenia, and malnutrition), the clinical signs of
sepsis temporally related to positive blood cultures, and the clinical
improvement with intravenous vancomycin and metronidazole
therapy suggest that the organism was a pathogen. Although sus-
ceptibility of C. paraputrificum to vancomycin has not been re-
ported in the literature, our patient's bacteremia did resolve while
he was receiving treatment with this drug.
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Generalized Infection with Bartonella henselae Following
Infection Due to Epstein-Barr Virus
Regional lymphadenopathy is the predominant clinical feature
of cat-scratch disease (CSD), which is usually preceded by an
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erythematous papule at the site of inoculation [1]. Bartonella
henselae has been isolated from lymph nodes of patients with CSD
and has been detected by PCR of specimens from these nodes
[1, 2]. We describe a patient with general lymphadenopathy who
underwent seroconversion to B. henselae following an Epstein-
Barr virus (EBV) infection.
A 19-year-old man was referred to Cantonal Hospital in Winter-
thur, Switzerland, on 27 October 1994 with a 4-week history of
intermittent high fever, fatigue, nausea, night sweats, and cough as
well as a weight loss of 8 kg. His primary care physician had tenta-
tively diagnosed his condition as lymphoma because of a newly
detected supraclavicular swelling after an episode of acute mono-
nucleosis in mid-August 1994. On admission to the hospital, the
patient looked ill; his temperature was 37.3°C. A left-sided supracla-
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vicular tender mass with a diameter of 5-8 cm was noted, and there
was a papulomacular erythematous skin lesion (1 cm in diameter) on
top of the mass; tender small axillary lymph nodes were also found.
The liver was palpable 5 cm subcostally.
The results of laboratory investigations were as follows: erythro-
cyte sedimentation rate, 80 mm/h; C reactive protein, 60 mg/L;
hemoglobin, 13.3 g/dL, WBC count, 15,900/mm 3 ; platelets,
664,000/mm 3 ; and alanine aminotransferase, 37 U/L. Serological
investigations for HIV, cytomegalovirus, and hepatitis viruses A,
B, and C as well as for Toxoplasma gondii were negative. IgM to
EBV viral capsid antigen was detected. A CT scan revealed the
supraclavicular lymph node, generalized abdominal lymphadenop-
athy with tumors of up to 3.6 cm in diameter, and slight enlarge-
ment of liver and spleen. Examination of biopsy specimens from
the cervical tumor revealed pus, but cultures of these specimens
were negative for bacteria and mycobacteria. Histological exami-
nation of the biopsy specimens showed necrotic granulomatous
inflammation with giant cells; stains for acid-fast bacteria and
argyrophilic bacilli were negative.
Upon specific questioning, the patient remembered having
played with a young cat some weeks before the onset of his present
illness. CSD was considered in the patient's differential diagnosis.
Serology performed as described in previous reports [3, 4] showed
an IgG titer of antibodies to B. henselae of 1:2,048. B. henselae-
specific DNA was detected in the tumor biopsy specimen by PCR
with use of primers that allow the simultaneous amplification of
B. henselae and Bartonella quintana followed by species-specific
hybridization [2].
The patient was treated with clarithromycin (500 mg twice daily
for 4 weeks), and he felt well afterwards. Six months later, an
abdominal ultrasonogram still showed slight hepatosplenomegaly.
IgM to EBV viral capsid antigen was no longer detected, and the
titer of IgG to B. henselae was 1:512. IgG seroconversion to
B. henselae and to nuclear antigen of EBV was documented. The
first serum specimen (obtained 20 August 1994) revealed an al-
ready positive titer of IgG to EBV viral capsid antigen (table 1).
This case emphasizes that CSD may be a severe systemic disease
and demonstrates that generalized lymphadenopathy should be
carefully investigated. EBV infection may have been reactivated
by B. henselae or EBV may have promoted dissemination of
B. henselae, which led to our patient's severe illness. Because of
the lack of controlled therapeutic trials, it is not known whether
antibiotic treatment of immunocompetent patients with CSD is
Table 1. Reciprocal titers to Bartonella henselae and Epstein-Barr
virus in a patient who presented with general lymphadenopathy.
Date of serum
	 IgG to 	 IgG to 	 IgG to





08/20/94 640 <10 <64
10/21/94 1,280 <10 1,024
11/09/94 1,280 10 2,048
05/04/95 2,560 >10 512
NOTE. EBNA = Epstein-Barr virus nuclear antigen; EBV VCA =
Epstein-Barr virus viral capsid antigen.
beneficial. Spontaneous resolution of CSD in immunocompetent
persons is common, but treatment is indicated for immunocom-
promised persons and may be indicated for immunocompetent
persons with systemic CSD.
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Isolation of Candida norvegensis from Clinical Specimens:
Four Case Reports
In recent years, we have seen a greater number of previously
unusual yeasts isolated from patient specimens; this circumstance
corresponds to the increasing population of immunocompro-
Reprints or correspondence: Dr. S. V. Hood, Monsall Unit, North Manches-
ter General Hospital, Delaunay's Road, Crumpsall, Manchester M8 6RL,
United Kingdom.
Clinical Infectious Diseases 1996; 23:1185-7
© 1996 by The University of Chicago. All rights reserved.
1058-4838/96/2305-0046$02.00
mised patients [1-3]. Candida norvegensis was originally isolated
in 1954 by Dietrichson [3a] and was later described by other
investigators [4]. We searched the world literature and found a
single case report of invasive diseak due to C. norvegensis [5].
We describe four seriously ill patients from whom C. norvegensis
was isolated; two of these patients had AIDS. To our knowledge,
C. norvegensis infection has not previously been reported among
patients with AIDS.
Patient 1. A 31-year-old HIV-infected man with a history of
Pneumocystis carinii pneumonia (PCP) and Kaposi's sarcoma had
oropharyngeal candidiasis (OPC), which was treated with fluco-
nazole. He developed cytomegalovirus esophagitis and probable
PCP when his CD4 cell count was 12 x 10 6/L. He had another
episode of OPC that responded to fluconazole therapy, but his
respiratory symptoms persisted, and C. norvegensis was isolated
